What is a major contributing factor in the development of metabolic bone disease in patients with IBD?

What is a major contributing factor in the development of metabolic bone disease in patients with IBD?

• A. Corticosteroids
• B. Aluminum toxicity
• C. Blood transfusion
• D. Oxalic acid deficiency

Answer: (A)

Corticosteroid exposure is the major contributing factor because these drugs directly disrupt bone remodeling and calcium balance. Steroids suppress osteoblast activity, promote osteoclast-mediated bone resorption, and reduce calcium absorption from the gut while increasing calcium loss in the urine. Over time, this leads to a rapid decline in bone density and higher fracture risk, which is a hallmark of metabolic bone disease in patients with inflammatory bowel disease who often rely on steroids for disease control. While inflammation and nutritional factors can contribute to bone loss, the strongest and most modifiable driver in this setting is steroid exposure. The other options don’t directly drive bone metabolism in the typical IBD context: aluminum toxicity is more relevant with heavy aluminum exposure and kidney issues, blood transfusion has no direct role, and oxalic acid deficiency is not a mechanism behind bone disease.

Corticosteroid exposure is the major contributing factor because these drugs directly disrupt bone remodeling and calcium balance. Steroids suppress osteoblast activity, promote osteoclast-mediated bone resorption, and reduce calcium absorption from the gut while increasing calcium loss in the urine. Over time, this leads to a rapid decline in bone density and higher fracture risk, which is a hallmark of metabolic bone disease in patients with inflammatory bowel disease who often rely on steroids for disease control. While inflammation and nutritional factors can contribute to bone loss, the strongest and most modifiable driver in this setting is steroid exposure. The other options don’t directly drive bone metabolism in the typical IBD context: aluminum toxicity is more relevant with heavy aluminum exposure and kidney issues, blood transfusion has no direct role, and oxalic acid deficiency is not a mechanism behind bone disease.